Technology Industry
Industry: Email Alert RSS FeedKaro Bio of Stockholm
BT Catalyst, April, 2000
- Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »
> Karo Bio of Stockholm, Sweden, has announced that it intends to acquire Novalon Pharmaceutical Corp. of Durham through a noncash issue. If Karo shareholders approve the acquisition later this month, the company stands to gain a leading position in the field of nuclear receptors. Karo plans to keep the Durham operation intact, and Novalon shareholders will hold 20 percent of Karo Bio after the acquisition.
COPYRIGHT 2000 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning